Yokohama, Japan

Rie Yoshida

This inventor holds 2 USPTO granted patents. Top assignee: Mitsubishi Chemical Corporation. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rie Yoshida. Retrieved from https://idiyas.com/inventor/rie-yoshida-i5ay3o25

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rie Yoshida: Innovator in Sialic Acid Derivatives

Introduction

Rie Yoshida is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of sialic acid derivatives. With a total of 2 patents, his work is poised to impact the treatment of neurodegenerative diseases.

Latest Patents

Yoshida's latest patents focus on sialic acid derivatives represented by a specific general formula. These derivatives are designed to enhance ChAT activity in cholinergic neurons, which is crucial for the prevention and therapy of senile dementia, including Alzheimer's disease. The innovative compounds include various structural components, such as steroidal compound residues and alkyl groups, which contribute to their medicinal properties.

Career Highlights

Rie Yoshida is currently associated with Mitsubishi Chemical Corporation, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential applications in treating age-related cognitive decline.

Collaborations

Yoshida collaborates with esteemed colleagues, including Haruyuki Chaki and Naoko Ando, who contribute to his research endeavors. Their combined expertise enhances the development of effective therapeutic solutions.

Conclusion

Rie Yoshida's innovative work in sialic acid derivatives represents a promising advancement in the field of medicine. His contributions may lead to significant improvements in the treatment of Alzheimer's disease and other forms of senile dementia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…